NEW YORK (360Dx) – Hennigsdorf, Germany-based Sphingotec said today that it has combined technology platforms with San Diego, California-based Nexus Dx to improve decision-making at the point of care in emergency departments and intensive care units.

Financial and other terms of the deal were not disclosed.

Holding company Polaris MediNet — jointly owned by Sphingotec and Nam Shin, CEO of Nexus Dx — merged the technology platforms.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sponsored by
Thermo Fisher Scientific

This webinar will discuss how ultra-highly sensitive and customizable targeted next-generation sequencing panels are applied in inherited disease research. 

Sponsored by

This online seminar will discuss the advantages of incorporating molecular testing into the microbiology laboratory to aid in the identification of relevant antibiotic resistance mechanisms.